# TiPS

> TiPS is a VC fund in Beijing backing Health Care, Biotechnology and Analytics. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 3
- Last investment: Dec 2019
- Lead investor: 33%
- Last updated: Aug 2026
- Website: http://www.thinkinpets.com/

TiPS is a VC fund in Beijing focused on Health Care and Biotechnology. TiPS provides health management and medical insurance services for pets.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Biotechnology | 2 | 67% |
| Analytics | 1 | 33% |
| Biopharma | 1 | 33% |
| Furniture | 1 | 33% |

10 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Genealogy | Founded by researchers from Harvard Medical School, Columbia University, Broad Institute and Carnegie Mellon, we are a forward-thinking bioinformatics and computational genetics company. Through utilizing computer science, bioinformatics and statistic driven techniques, our goal is to develop novel machine learning and deep learning algorithms. Asindustry leaders, we can both develop and deliver the most accurate DNA prediction solutions in the world. | $841.7K | Seed | Dec 05, 2019 |  |
| Plcoskin | Plcoskin is a MedTech company specializing in reconstructive plastic surgery and regenerative skincare. They have developed a scaffold that removes the need for cadaver-sourced material used in breast reconstruction surgery, making procedures safer and cheaper. Plcoskin’s scaffolds are made with synthetic PCL, a biodegradable material that iscommonly used to create surgical sutures. Unlike competitors' products that remain in the body for a lifetime, Plcoskin’s PCL scaffolds are absorbed and replaced with the recipient’s own natural tissues, minimizing the possibility of long-term side effects. As they do not contain any dangerous chemicals, they are also 50% safer than cadaver-sourced scaffolds.Costs for reconstructive breast surgery are brought down by 40% to only $3 thousand per breast. Furthermore, much less handling time is required, reducing average surgery durations from an hour and a half to only 30 minutes. The mesh design of the scaffolds mitigates the need for an additional follow-up reconstructive surgery, something that is common when using cadaver-sourced scaffolds.Plcoskin has also developed Youlief, a cosmeceutical product & therapeutic device pipeline that helps fund R&D for their medical devices. Youlief is available in the US, Europe, Taiwan, Singapore and Japan. | $417.3K | Seed | Sep 30, 2019 |  |
| Archisketch | Archisketch is an IT Consulting and Service providing firm that offers Cloud Based 3D Interior Designing and Home Furnishing Platform. |  | Seed | Mar 01, 2019 |  |

3 of 3 investments shown.

## Co-investors
- [TheVentures](https://shizune.co/investors/profile/theventures) — VC Fund, 1 deal together
- [TIPS Program](https://shizune.co/investors/profile/tips-program) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Biotech Investors in South Korea](https://shizune.co/investors/biotech-investors-south-korea)
- [Biotech VC Funds in South Korea](https://shizune.co/investors/biotech-vc-funds-south-korea)
- [Artificial intelligence Investors in South Korea](https://shizune.co/investors/artificial-intelligence-investors-south-korea)
- [Artificial intelligence VC Funds in South Korea](https://shizune.co/investors/artificial-intelligence-vc-funds-south-korea)
- [Health Care Investors in South Korea](https://shizune.co/investors/health-care-investors-south-korea)
- [Health Care VC Funds in South Korea](https://shizune.co/investors/health-care-vc-funds-south-korea)

## FAQ

### What does TiPS invest in?

TiPS invests primarily in Health Care, Biotechnology and Analytics startups, most often at Seed stage. Most of the 3 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did TiPS last invest?

The most recent investment recorded for TiPS closed in Dec 2019. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co